Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.65 USD | +5.61% | +6.60% | -37.15% |
Jun. 14 | Transcript : Aurinia Pharmaceuticals Inc. - Shareholder/Analyst Call | |
Jun. 07 | ILJIN SNT Co Provides Information to Shareholders of Aurinia Pharmaceuticals | CI |
Financials (USD)
Sales 2024 * | 227M | Sales 2025 * | 282M | Capitalization | 806M |
---|---|---|---|---|---|
Net income 2024 * | 9M | Net income 2025 * | 71M | EV / Sales 2024 * | 1.81 x |
Net cash position 2024 * | 395M | Net cash position 2025 * | 448M | EV / Sales 2025 * | 1.27 x |
P/E ratio 2024 * |
97.4
x | P/E ratio 2025 * |
11.9
x | Employees | 300 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.93% |
Latest transcript on Aurinia Pharmaceuticals Inc.
1 day | +5.61% | ||
1 week | +6.60% | ||
Current month | +4.24% | ||
1 month | +8.65% | ||
3 months | +11.00% | ||
6 months | -37.43% | ||
Current year | -37.15% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Martin
FOU | Founder | 52 | 93-06-15 |
Peter Greenleaf
CEO | Chief Executive Officer | 54 | 19-04-28 |
Robert Foster
FOU | Founder | 65 | 93-06-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Foster
FOU | Founder | 65 | 93-06-15 |
R. MacKay-Dunn
BRD | Director/Board Member | 73 | 19-06-25 |
Peter Greenleaf
CEO | Chief Executive Officer | 54 | 19-04-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.01% | 9 M€ | -.--% | - | |
0.01% | 775 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 5.65 | +5.61% | 2,873,167 |
24-06-13 | 5.35 | -1.83% | 1,234,408 |
24-06-12 | 5.45 | -1.80% | 814,701 |
24-06-11 | 5.55 | +2.78% | 955,171 |
24-06-10 | 5.4 | +1.89% | 653,344 |
Delayed Quote Nasdaq, June 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.15% | 806M | |
+18.15% | 124B | |
+18.02% | 112B | |
-12.75% | 22.22B | |
+5.07% | 22.94B | |
-39.94% | 16.87B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- AUPH Stock